In April this year, Sun Pharma and Ranbaxy announced a $4-billion deal that would create one of the five largest specialty generics companies in the world.
This is a rare instance where CCI has ordered a scrutiny of a proposed M&A deal to ensure compliance with fair trade regulations.
The JV with Navin Fluorine will be engaged in specialty fluorochemicals with a focus on applications in healthcare.
VCCircle is proud to present its 2nd edition of VCCircle Healthcare Awards 2014, as a part of the summit on September 25th, at The Taj Mahal Palace, Mumbai.
In two years, Aster DM plans to add 1,500 beds through green-field projects and 1,000 more through acquisitions.
Retail investor will have little to cheer from now onwards.
SEBI has reduced their quota from 35% to 10%.and...
Will it be available for subscription tommorow for the retail investors.
Agree. It is with supreme irony when managers who call me "over qualified" are not qualified to do so.
India is a valuable market for Uber and this circular would mean that Uber would tweak its collection payment...